Drug profile

The FDA adverse-event record for Unspecified Medicated Shampoo

28 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Unspecified Medicated Shampoo. Species, reactions, and outcomes follow.

#1514 of 2,679
by report volume (all drugs)
28
adverse-event reports
14.3%
death-coded share
Dog
most-reported species
Verify with FDA CVM →

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Unspecified Medicated Shampoo ranks #1493 of 2679 by total reports (28). Death-coded-share rank requires at least 50 reports. National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1)
97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1)
#1493
This drug, reports of 2679

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Unspecified Medicated Shampoo has 28 reports now versus 27 in that prior snapshot: 1 more (3.7%).

Report change
+1
Death-coded reports
+0
Death-coded share
−0.5 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Unspecified Medicated Shampoo changes

Signature read: death-coded share at 14.3% is the most distinctive stamp on Unspecified Medicated Shampoo's FDA AER row.

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
28
Total Reports
4
Deaths Reported
14.3%
Death-coded share of reports

Active Ingredients

Unspecified Medicated Shampoo

Administration Routes

TopicalUnknown

Species Affected

Dog 28

Most Affected Breeds

Retriever - Labrador 4
Pit Bull 2
Terrier - Yorkshire 2
Retriever - Golden 2
Dog (unknown) 2
Shepherd Dog - Belgian Malinois 2
Beagle 1
Rottweiler 1
Collie (unspecified) 1
Havanese 1

Most Reported Reactions

Lack of efficacy (ectoparasite) - flea 7
Hair loss NOS 4
Anorexia 3
Lethargy (see also Central nervous system depression in 'Neurological') 3
Weight loss 3
Behavioural disorder NOS 3
Death 3
Skin and tissue infection NOS 3
Skin lesion NOS 3
Pruritus 3
Vocalisation 2
Erythema (for urticaria see Immune SOC) 2

Outcome Breakdown

Outcome Unknown
10 (35.7%)
Recovered/Normal
7 (25.0%)
Ongoing
7 (25.0%)
Died
3 (10.7%)
Euthanized
1 (3.6%)

Unspecified Medicated Shampoo Adverse Event Insights

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

What to do with this drug

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Unspecified Medicated Shampoo (#1514 of 2,679 by report volume); death-coded 14.3%. PlainBreed drug row · death-coded share stamp 14.3% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →